92 results
424B3
BTMD
biote Corp - Ordinary Shares
10 May 24
Prospectus supplement
4:12pm
and support services.
Coverage and reimbursement from third party payors, such as commercial health insurers and governmental health care programs
424B3
BTMD
biote Corp - Ordinary Shares
10 May 24
Prospectus supplement
4:10pm
and support services.
Coverage and reimbursement from third party payors, such as commercial health insurers and governmental health care programs
8-K
EX-99.1
BTMD
biote Corp - Ordinary Shares
7 May 24
Biote Reports First Quarter 2024 Financial Results
4:18pm
, 2024—Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization
8-K
EX-99.1
BTMD
biote Corp - Ordinary Shares
29 Apr 24
Biote Announces Definitive Settlement with Founder
4:24pm
IRVING, TX – April 29, 2024 – biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through
424B3
r90zxlhp2
9 Apr 24
Prospectus supplement
4:28pm
424B3
2jxt7n
9 Apr 24
Prospectus supplement
4:25pm
POS AM
uv61 nlvp
29 Mar 24
Prospectus update (post-effective amendment)
5:34pm
POS AM
EX-10.22
oaunlfza
29 Mar 24
Prospectus update (post-effective amendment)
5:34pm
POS AM
EX-10.22
ivc9i2yu7dc
29 Mar 24
Prospectus update (post-effective amendment)
5:34pm
POS AM
1lvynrbrwdwdkl
29 Mar 24
Prospectus update (post-effective amendment)
5:34pm
8-K
EX-99.1
2e4hb3dl
12 Mar 24
Biote Reports Fourth Quarter and Full Year 2023 Financial Results
4:43pm
8-K
EX-99.1
v1vmp5dlaemd2htr2uw
20 Feb 24
Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder’s Shares
4:19pm
8-K
EX-99.1
om73kj77bgcai a1r0
25 Jan 24
Biote Announces $20 Million Share Repurchase Authorization
4:33pm
8-K
EX-99.1
lrb175wev
17 Jan 24
Biote Provides Preliminary 2023 Results and Initial 2024 Guidance
4:39pm
8-K
EX-99.2
fb066m84q6np
17 Jan 24
Biote Provides Preliminary 2023 Results and Initial 2024 Guidance
4:39pm
424B3
5mbashe wl
17 Jan 24
Prospectus supplement
4:36pm